Skip to nav Skip to content

HCV: Hepatitis C Virus

Facebook Twitter LinkedIn Email

Viral hepatitis is a silent epidemic. According to the United States Department of Health and Human Services, it is estimated that 2.7 to 3.9 million persons are infected with the hepatitis C virus (HCV) in the United States alone. An enormous public health danger lies in the fact that many infected patients are unaware of their diseased state. HCV's slow disease progression can lead to liver cirrhosis or hepatocellular carcinoma, which ultimately requires transplantation or causes mortality.

HCV_Treatment.jpg

Expert Guidance on Treatment

Up-to-date guidance for the treatment of HCV infection from IDSA and the American Association for the Study of Liver Diseases, in collaboration with the International Antiviral Society-USA.

>> HCVguidelines.org

HCV_MOC.jpg

Maintenance of Certification

IDSA offers a Maintenance of Certification module specific to Hepatitis C.

>> Read more about IDSA MOC modules


HCV Clinical Guidance - Additional Information

Additional HCV resources from the Department of Veterans Affairs, Medline Plus, and more.

2012 Update on the Management and Treatment of Hepatitis C Virus Infection (PDF)

The Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office developed updated recommendations for standard of care for hepatitis C patients. [April 2012]

HCV Treatment Options - Video

Presented at IDWeek 2012, this video teaches how to discuss the benefits and risks of new HCV therapies to various patient populations, explain the treatment success/failure rates, analyze the therapy costs and insurance challenges, and develop a working knowledge of the practice infrastructure necessary to treat these patients.

HCV - Continuing Medical Education

IDSA has compiled a list of HCV-related CME opportunities.

HCV Research Resources

Resources from the Annals of Internal Medicine, the US Department of Health and Human Services, and others on the latest in hepatitis C research.

AASLD Guideline: Management of Hepatocellular Carcinoma (PDF)

AASLD's 2005 guidelines have been updated to include new information about the management of hepatocelluar carcinoma.

Management and Treatment of Patients with Cirrhosis and Portal Hypertension Review (PDF)

Recommendations from the Department of Veterans Affairs to manage and treat cirrhosis and portal hypertension based on evidence in literature, including randomized clinical trials and met-analyses.

HCV Management - Additional Information

Additional hepatitis C management resources from the Department of Veterans Affairs, the Forum for Collaborative HIV Research, and others.

HCV Screening Letter

IDSA encourages Society members to reach out to their primary care partners in support of the USPSTF's recent recommendations on HCV screening.

HCV Rx Appeal Letter Template

In response to action taken by some State Medicaid programs to restrict the specialties of providers who can prescribe drug therapies to treat hepatitis C virus (HCV), IDSA has developed an appeals letter template recommending that Infectious Diseases (ID) Specialists and other HIV providers be covered prescribers of all HCV medications. The letter provides succinct evidence points as well as a link to the appeals letter sent to the Center for Medicare and Medicaid Services (CMS).

CDC Recommendations for Screening of Persons Born During 1945-1965 for Chronic Hepatitis C Virus Infection (PDF)

Research has determined that the population born between 1945 and 1965 is five times more likely to test positive for hepatitis C antibodies. This recommendation presents information concerning testing, management, and future endeavors to decrease to spread of hepatitis C.

Hepatitis C Virus Infection Testing Diagnosis Algorithm (PDF)

The Centers for Disease Control and Prevention has developed an algorithm that will guide physicians on subsequent actions after a patient is positive for hepatitis C antibodies.

Reference for Interpretation of Hepatitis C Virus Test Results (PDF)

The Centers for Disease Control and Prevention makes available a chart on how to interpret hepatitis C test results and any subsequent additional tests that may be required to obtain a comprehensive diagnosis.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.